MedAdvisor Limited (MDR.AX)
AUD 0.09
(-1.05%)
AUD 0.09
(-1.05%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 47.19 Million AUD | -0.52% |
| 2023 | 47.44 Million AUD | 8.09% |
| 2022 | 43.89 Million AUD | 36.86% |
| 2021 | 32.07 Million AUD | 654.51% |
| 2020 | 4.25 Million AUD | 35.81% |
| 2019 | 3.13 Million AUD | 41.55% |
| 2018 | 2.21 Million AUD | 26.7% |
| 2017 | 1.74 Million AUD | 47.74% |
| 2016 | 1.18 Million AUD | 287.86% |
| 2015 | 304.58 Thousand AUD | -22.8% |
| 2014 | 394.51 Thousand AUD | -50.46% |
| 2013 | 796.36 Thousand AUD | 56.82% |
| 2012 | 507.82 Thousand AUD | 89.3% |
| 2011 | 268.26 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 47.19 Million AUD | -0.52% |
| 2024 Q2 | 63.52 Million AUD | 0.0% |
| 2024 Q4 | 47.19 Million AUD | 0.0% |
| 2023 Q4 | 47.44 Million AUD | 0.0% |
| 2023 FY | 47.44 Million AUD | 8.09% |
| 2023 Q2 | 59.39 Million AUD | 0.0% |
| 2022 FY | 43.89 Million AUD | 36.86% |
| 2022 Q2 | 36.22 Million AUD | 0.0% |
| 2022 Q4 | 43.89 Million AUD | 0.0% |
| 2021 Q4 | 32.07 Million AUD | 0.0% |
| 2021 Q2 | 40.97 Million AUD | 0.0% |
| 2021 FY | 32.07 Million AUD | 654.51% |
| 2020 Q4 | 4.25 Million AUD | 0.0% |
| 2020 Q2 | 4.42 Million AUD | 0.0% |
| 2020 FY | 4.25 Million AUD | 35.81% |
| 2019 FY | 3.13 Million AUD | 41.55% |
| 2019 Q2 | 3.18 Million AUD | 0.0% |
| 2019 Q4 | 3.13 Million AUD | 0.0% |
| 2018 Q2 | 2.29 Million AUD | 0.0% |
| 2018 FY | 2.21 Million AUD | 26.7% |
| 2018 Q4 | 2.21 Million AUD | 0.0% |
| 2017 FY | 1.74 Million AUD | 47.74% |
| 2017 Q2 | 1.99 Million AUD | 0.0% |
| 2017 Q4 | 1.74 Million AUD | 0.0% |
| 2016 Q2 | 860.96 Thousand AUD | 0.0% |
| 2016 FY | 1.18 Million AUD | 287.86% |
| 2016 Q4 | 1.18 Million AUD | 0.0% |
| 2015 Q4 | 304.58 Thousand AUD | -61.04% |
| 2015 Q3 | 781.76 Thousand AUD | 0.0% |
| 2015 Q1 | - AUD | -100.0% |
| 2015 FY | 304.58 Thousand AUD | -22.8% |
| 2014 Q4 | 394.51 Thousand AUD | 0.0% |
| 2014 FY | 394.51 Thousand AUD | -50.46% |
| 2013 FY | 796.36 Thousand AUD | 56.82% |
| 2013 Q4 | 796.36 Thousand AUD | 0.0% |
| 2012 FY | 507.82 Thousand AUD | 89.3% |
| 2012 Q4 | 507.82 Thousand AUD | 0.0% |
| 2011 FY | 268.26 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alcidion Group Limited | 27.52 Million AUD | -71.509% |
| Artrya Limited | 2.2 Million AUD | -2037.646% |
| Beamtree Holdings Limited | 12.51 Million AUD | -277.081% |
| Cogstate Limited | 25.32 Million AUD | -86.343% |
| Careteq Limited | 3.29 Million AUD | -1332.432% |
| Doctor Care Anywhere Group PLC | 32.27 Million AUD | -46.245% |
| Emyria Limited | 3 Million AUD | -1473.175% |
| Global Health Limited | 5.97 Million AUD | -689.732% |
| HITIQ Limited | 5.2 Million AUD | -807.439% |
| Intelicare Holdings Limited | 1.68 Million AUD | -2700.967% |
| ImExHS Limited | 6.66 Million AUD | -607.672% |
| Mach7 Technologies Limited | 21.17 Million AUD | -122.906% |
| Oakridge International Limited | 776.75 Thousand AUD | -5976.5% |
| Opyl Limited | 501.75 Thousand AUD | -9306.769% |
| PainChek Limited | 2.89 Million AUD | -1532.202% |
| Pro Medicus Limited | 69.69 Million AUD | 32.28% |
| Resonance Health Limited | 9.35 Million AUD | -404.732% |
| Singular Health Group Ltd | 909.58 Thousand AUD | -5089.093% |
| Total Brain Limited | 4.43 Million AUD | -963.119% |